METEOR-1: A phase I study of the safety and efficacy of the protein arginine methyltransferase 5 (PRMT5) inhibitor GSK3326595 in advanced solid tumors Meeting Abstract
| Authors: | Postel-Vinay, S.; Italiano, A.; Martin Romano, P.; Cassier, P. A.; Siu, L. L.; Lossos, I. S.; Hilton, J. F.; Mckean, M. A.; Strauss, J.; Falchook, G. S.; de Jonge, M. J. A.; Opdam, F. L.; Rasco, D.; Vermaat, J. S.; Crossman, T.; Zajac, M.; Hainline, A.; Kremer, B.; Barbash, O.; Gounder, M. M. |
| Abstract Title: | METEOR-1: A phase I study of the safety and efficacy of the protein arginine methyltransferase 5 (PRMT5) inhibitor GSK3326595 in advanced solid tumors |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S746 |
| End Page: | S747 |
| Language: | English |
| ACCESSION: | WOS:000866211600450 |
| DOI: | 10.1016/j.annonc.2022.07.585 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 456MO -- Source: Wos |
